(HealthDay News) — Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Depression
This study aims to determine whether certain proteins in the blood related to inflammation and neuroendocrine function can serve as markers of depression. The study involves a single visit for a clinical interview and blood draw and a follow-up phone call 8 to 12 weeks later. The research site is in Brighton, Mass.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/depression.aspx.
—–
Alzheimer’s Disease or Medication for Memory Loss
This study is trying to find people who are taking medications for memory loss or have mild-to-moderate Alzheimers disease. Qualified participants will receive study-related health assessments and investigational drugs at no cost and study-related care from the study doctor at the healthcare facility. The research site is in Oklahoma City, Okla.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/alzheimer’s_disease.aspx.
—–
Healthy, White Volunteers
This study is for an investigational study drug. To qualify, you must be healthy, white and between 20 and 45 years old. Qualified participants may receive study-related services at no cost and compensation up to $1,860. The research site is in Glendale, Calif.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/healthy_volunteers.aspx.
—–
Copyright 2010ClinicalConnection.com. All rights reserved.